Literature DB >> 17956913

Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Christina Marik1, Paul A Felts, Jan Bauer, Hans Lassmann, Kenneth J Smith.   

Abstract

Lesions obtained early in the course of multiple sclerosis (MS) have been studied immunocytochemically, and compared with the early stages of the experimental lesion induced in rats by the intraspinal injection of lipopolysaccharide. Large hemispheric or double hemispheric sections were examined from patients who had died in the course of acute or early relapsing multiple sclerosis. In MS patients exhibiting hypoxia-like lesions [Pattern III; Lucchinetti et al. Ann Neurol (2000) 47: 707-17], focal areas in the white matter showed mild oedema, microglial activation and mild axonal injury in the absence of overt demyelination. In such lesions T-cell infiltration was mild and restricted to the perivascular space. Myeloperoxidase and the inducible form of nitric oxide synthase were expressed primarily by microglia, and the activated form of these cells was associated with extracellular deposition of precipitated fibrin. In addition, these lesions showed up-regulation of proteins involved in tissue preconditioning. When active demyelination started, lesions were associated with massive T-cell infiltration and microglia and macrophages expressed all activation markers studied. Similar tissue alterations were found in rats in the pre-demyelinating stage of lesions induced by the focal injection of bacterial lipopolysaccharide into the spinal white matter. We suggest that the areas of microglial activation represent an early stage of tissue injury, which precedes the formation of hypoxia-like demyelinated plaques. The findings indicate that mechanisms associated with innate immunity may play a role in the formation of hypoxia-like demyelinating lesions in MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956913      PMCID: PMC2981817          DOI: 10.1093/brain/awm236

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  43 in total

1.  The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion.

Authors:  F W Gay; T J Drye; G W Dick; M M Esiri
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

2.  Axonal damage in acute multiple sclerosis lesions.

Authors:  B Ferguson; M K Matyszak; M M Esiri; V H Perry
Journal:  Brain       Date:  1997-03       Impact factor: 13.501

3.  Macrophage populations associated with multiple sclerosis plaques.

Authors:  M M Esiri; M C Reading
Journal:  Neuropathol Appl Neurobiol       Date:  1987 Nov-Dec       Impact factor: 8.090

4.  HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy.

Authors:  N J Stam; T M Vroom; P J Peters; E B Pastoors; H L Ploegh
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

5.  Generation and characterization of mouse monoclonal antibodies to the myelin-associated glycoprotein (MAG).

Authors:  M J Dobersen; J A Hammer; A B Noronha; T D MacIntosh; B D Trapp; R O Brady; R H Quarles
Journal:  Neurochem Res       Date:  1985-04       Impact factor: 3.996

6.  Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.

Authors:  P A Narayana; T J Doyle; D Lai; J S Wolinsky
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

7.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

8.  Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis.

Authors:  M Filippi; M A Rocca; G Martino; M A Horsfield; G Comi
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

9.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein.

Authors:  C Linington; M Bradl; H Lassmann; C Brunner; K Vass
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

10.  Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen.

Authors:  D C Altieri; R Bader; P M Mannucci; T S Edgington
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

View more
  113 in total

1.  Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.

Authors:  Christian Schachtrup; Jae K Ryu; Matthew J Helmrick; Eirini Vagena; Dennis K Galanakis; Jay L Degen; Richard U Margolis; Katerina Akassoglou
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

2.  In vitro and in vivo induction and activation of nNOS by LPS in oligodendrocytes.

Authors:  S Y Yao; A Ljunggren-Rose; N Chandramohan; W O Whetsell; S Sriram
Journal:  J Neuroimmunol       Date:  2010-08-19       Impact factor: 3.478

3.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

4.  Glatiramer acetate modulates TNF-α and IL-10 secretion in microglia and promotes their phagocytic activity.

Authors:  Refik Pul; Darius Moharregh-Khiabani; Jelena Škuljec; Thomas Skripuletz; Niklas Garde; Elke Verena Voss; Martin Stangel
Journal:  J Neuroimmune Pharmacol       Date:  2010-11-03       Impact factor: 4.147

Review 5.  Fibrinogen signal transduction in the nervous system.

Authors:  J K Ryu; D Davalos; K Akassoglou
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

Review 6.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

Review 7.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

8.  Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.

Authors:  Norah G Verbout; Xiaolin Yu; Laura D Healy; Kevin G Phillips; Erik I Tucker; András Gruber; Owen J T McCarty; Halina Offner
Journal:  Metab Brain Dis       Date:  2014-05-09       Impact factor: 3.584

Review 9.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

10.  Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders.

Authors:  Nilufer Kale; Murat Icen; Jale Agaoglu; Isil Yazici; Osman Tanik
Journal:  Neurol Sci       Date:  2008-10-14       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.